AngioDynamics ANGO Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's other income, net (note 6)?
- AngioDynamics (ANGO) reported other income, net (note 6) of $4.97M in Q4 2025.
- How has AngioDynamics's other income, net (note 6) changed year-over-year?
- AngioDynamics's other income, net (note 6) decreased by 8.5% year-over-year, from $5.43M to $4.97M.
- What is the long-term trend for AngioDynamics's other income, net (note 6)?
- Over 3 years (2022 to 2025), AngioDynamics's other income, net (note 6) has grown at a 88.2% compound annual growth rate (CAGR), from -$790K to $5.27M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.